May 25, 2010 -- Sandoz today announced the introduction in the US of valacyclovir hydrochloride (HCl) tablets, a generic equivalent of Valtrex. Valacyclovir HCl tablets are indicated for treatment of ...

Research Triangle Park, N.C., January 1, 2004 – GlaxoSmithKline today announced the publication of results from a clinical trial evaluating VALTREX® (valacyclovir HCl), an oral antiviral, in the ...

May 19, 2004 (Boston) — Valacyclovir is equally as effective as ganciclovir in preventing cytomegalovirus (CMV) in renal transplantation, and it may be more cost-effective as well, researchers ...

The Indian Patent Office has granted patent to Aurobindo Pharma for its process for the preparation of its antiviral drug valacyclovir, which has been sold in US and other countries under the trade ...

Reactivation of latent VZV remains a significant cause of morbidity after SCT. Twenty-five percent or more of patients undergoing SCT will experience zoster within the first year after transplant.

Co announces it has received tentative approval for its Abbreviated New Drug Application for Valacyclovir Hydrochloride Tablets, 500mg and 1000mg. Valacyclovir Hydrochloride Tablets are the generic ...

Hematopoietic stem cell transplantation (SCT), being performed with an increasing frequency for a variety of both malignant and non-malignant conditions, is associated with the occurrence of many ...

Ranbaxy Laboratories announces it has reached an agreement with GlaxoSmithKline (GSK) resulting in a dismissal of their U.S. litigation with regard to Valtrex. The lawsuit in the U.S. was related to ...

Valacyclovir is an antiviral agent, prescribed for herpes zoster (shingles), genital herpes and herpes labialis (cold sores). Valaciclovir may increase the central nervous system depressant (CNS ...

About The Study: Valacyclovir, an antiviral medication, was not efficacious with cognitive worsening for the primary outcome and it is not recommended to treat individuals with early symptomatic ...

August 24, 2010 — Exposure to acyclovir or valacyclovir in the first trimester of pregnancy is not associated with an increased risk for major birth defects, according to the results of a large, ...